Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:05 pm Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Novo Holdings A/S | 4,180,550 9.000% | 4,180,550 (New Position) | Filing History |
| 2026-08-14 09:01 am Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Avoro Capital Advisors LLC | 3,298,236 7.060% | 3,298,236 (New Position) | Filing History |
| 2026-08-12 10:28 am Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Capital International Investors | 3,603,876 7.700% | 3,603,876 (New Position) | Filing History |
| 2026-08-07 09:31 am Purchase | 2026-08-03 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Invus Public Equities, L.P. | 2,366,235 5.100% | 2,366,235 (New Position) | Filing History |
| 2026-08-06 10:28 am Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | FMR LLC | 3,697,837 7.900% | 3,697,837 (New Position) | Filing History |
| 2026-08-05 10:38 am Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Sofinnova Crossover II SLP | 2,511,212 5.400% | 2,511,212 (New Position) | Filing History |
| 2026-05-11 5:46 pm Purchase | 2026-05-04 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | RA CAPITAL MANAGEMENT L.P. | 7,729,773 16.600% | 7,729,773 (New Position) | Filing History |
| 2026-05-11 4:43 pm Purchase | 2026-05-04 | 13D | HEMAB THERAPEUTICS HLDGS INC C COAG | AI DEN-MAB LLC | 4,876,344 10.400% | 4,876,344 (New Position) | Filing History |
| 2026-05-08 4:18 pm Purchase | 2026-05-01 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Deep Track Capital, LP | 3,600,996 8.150% | 3,600,996 (New Position) | Filing History |